CLCN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.620200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.223600E-01
Normal-vs-Stage2
6.466800E-01
Normal-vs-Stage3
4.632400E-01
Normal-vs-Stage4
7.847400E-01
Stage1-vs-Stage2
1.089820E-01
Stage1-vs-Stage3
1.077190E-01
Stage1-vs-Stage4
3.080400E-01
Stage2-vs-Stage3
1.993040E-01
Stage2-vs-Stage4
8.062400E-01
Stage3-vs-Stage4
1.697790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.833800E-01
Normal-vs-AfricanAmerican
5.486800E-01
Normal-vs-Asian
3.357600E-01
Caucasian-vs-AfricanAmerican
6.232600E-01
Caucasian-vs-Asian
5.084600E-01
AfricanAmerican-vs-Asian
9.959400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.074800E-01
Normal-vs-Female
6.319800E-01
Male-vs-Female
7.025000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.313800E-01
Normal-vs-Age(41-60Yrs)
6.235600E-01
Normal-vs-Age(61-80Yrs)
7.003200E-01
Normal-vs-Age(81-100Yrs)
8.357000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.032000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.071600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.222800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.974600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.523600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.634400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.245600E-01
Normal-vs-Daily Drinker
6.593200E-01
Normal-vs-Weekly Drinker
8.150600E-01
Normal-vs-Occasional Drinker
5.714800E-01
Normal-vs-Social Drinker
7.895200E-01
Non Drinker-vs-Daily Drinker
6.863000E-01
Non Drinker-vs-Weekly Drinker
3.417800E-01
Non Drinker-vs-Occasional Drinker
9.206400E-01
Non Drinker-vs-Social Drinker
4.106200E-01
Daily Drinker-vs-Weekly Drinker
5.941400E-01
Daily Drinker-vs-Occasional Drinker
7.499200E-01
Daily Drinker-vs-Social Drinker
6.687800E-01
Weekly Drinker-vs-Occasional Drinker
4.189200E-01
Weekly Drinker-vs-Social Drinker
9.127000E-01
Occasional Drinker-vs-Social Drinker
4.803000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.375440E-01
Normal-vs-Grade 2
8.038300E-02
Normal-vs-Grade 3
8.804400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.826000E-01
Grade 1-vs-Grade 3
2.843200E-01
Grade 1-vs-Grade 4
1.375440E-01
Grade 2-vs-Grade 3
3.057000E-01
Grade 2-vs-Grade 4
8.038300E-02
Grade 3-vs-Grade 4
8.804400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.879200E-01
Normal-vs-NonDiabetic
5.720800E-01
Diabetic-vs-NonDiabetic
5.778000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.825200E-01
Normal-vs-NoPancreatitis
6.843200E-01
Pancreatitis-vs-NoPancreatitis
5.550600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.965800E-01
Normal-vs-N1
6.324400E-01
N0-vs-N1
8.125600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.981600E-01
Normal-vs-TP53-NonMutant
4.846000E-01
TP53-Mutant-vs-TP53-NonMutant
4.966200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
